Clinical Trials Browser

Hypertension, Portal × Bevacizumab × Clear all

NCT00280007 2010-04-22

Transarterial Chemoembolisation Plus Bevacizumab for Treatment of Hepatocellular Carcinoma

Phase 2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Hypertension, Portal